As Europe’s premiere microbiome conference tightly focused on the development of microbiome-based therapeutics, this is your prime opportunity to expand your microbiome-based drug development capabilities and business potential as we aim to deliver clinical results and ensure therapeutic microbiome approval in Europe.

No matter what stage of development you’re focusing on, this is your one-stop shop for microbiome-based drug development from early discovery to late-phase manufacturing!

What’s New for 2024:

• Highlighting early-stage organisations and their novel technologies in our brand-new technology showcase where we welcome Centre for Genomic Regulation, Recolony and Synflora to give quick fire presentations to showcase their work.
• Discover our new enabling technologies track to learn more about the exciting artificial intelligence, integrated -omics analysis and improved manufacturing capabilities among the other technologies that are accelerating microbiome-based drug development.
• Strengthen your regulatory understanding and enhance decision-making by uncovering global regulations to address updated SoHo frameworks, explore considerations for engineered microbes and consolidate agencies interactions

To know more visit: https://ter.li/zi3xwf